MedTrace Logo

A Study in Patients With Complicated Type B Aortic Dissection Treated With the E-nya Thoracic Stent Graft

NCT04378361 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-07-25

No results posted yet for this study

Summary

The CONFORM-TAD post-market clinical follow-up study is undertakento evaluate the prevention of death related to the treatment of a complicated acute, subacute or chronic type B aortic dissection with the E-nya Thoracic Stent Graft System. The secondary objective is to evaluate safety and clinical performance of the device.

Conditions

  • Vascular Diseases

Interventions

DEVICE

endovascular repair

Endovascular repair of complicated acute, subacute or chronic type B aortic dissection with double lumen

Sponsors & Collaborators

  • MedPass International

    collaborator INDUSTRY

  • JOTEC GmbH

    lead INDUSTRY

Principal Investigators

  • Jan Brunkwall, Prof. · Brumed

  • Jost P. Schäfer, Prof. · University Hospital Schleswig-Holstein (UKSH) Kiel

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-25
Primary Completion
2024-07-24
Completion
2024-07-24

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04378361 on ClinicalTrials.gov